NovaBay Pharmaceuticals, Inc. Weighted Average Shares Diluted Growth

Weighted Average Shares Diluted Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Weighted Average Shares Diluted Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Weighted Average Shares Diluted Growth for the quarter ending June 30, 2022 was 0.24 (a 20.22% increase compared to previous quarter)
  • Year-over-year quarterly Weighted Average Shares Diluted Growth increased by 95.9%
  • Annual Weighted Average Shares Diluted Growth for 2021 was 0.24 (a -60.6% decrease from previous year)
  • Annual Weighted Average Shares Diluted Growth for 2020 was 0.62 (a 131.04% increase from previous year)
  • Annual Weighted Average Shares Diluted Growth for 2019 was 0.27 (a 137.37% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Weighted Average Shares Diluted Growth of NovaBay Pharmaceuticals, Inc.

Most recent Weighted Average Shares Diluted Growthof NBY including historical data for past 10 years.

Interactive Chart of Weighted Average Shares Diluted Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Weighted Average Shares Diluted Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.24 0.2
2021 0.24 0.12 0.4 0.49 0.24
2020 0.62 0.72 0.63 0.64 0.62
2019 0.27 0.35 0.08 0.03 0.27
2018 0.11 0.12 0.13 0.09 0.11
2017 0.63 0.4 1.07 2.74 0.63
2016 2.38 2.69 1.79 0.88 2.38
2015 0.4 0.45 0.31 0.2 0.4
2014 0.3 0.36 0.36 0.23 0.3
2013 0.3 0.28 0.3 0.29 0.3
2012 0.14 0.05 0.22 0.22 0.14
2011 0.1 0.1

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology